These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 8809464

  • 1. Immunopathogenesis of recurrent vulvovaginal candidiasis.
    Fidel PL, Sobel JD.
    Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
    [Abstract] [Full Text] [Related]

  • 2. Immunity to Candida.
    Fidel PL.
    Oral Dis; 2002 Jul; 8 Suppl 2():69-75. PubMed ID: 12164664
    [Abstract] [Full Text] [Related]

  • 3. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
    Fidel PL, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD.
    J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
    [Abstract] [Full Text] [Related]

  • 4. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
    Fidel PL.
    Int Rev Immunol; 2002 Sep; 21(6):515-48. PubMed ID: 12650240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
    Fidel PL, Lynch ME, Conaway DH, Tait L, Sobel JD.
    Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".
    Yano J, Peters BM, Noverr MC, Fidel PL.
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203543
    [Abstract] [Full Text] [Related]

  • 10. Candida-specific antibodies during experimental vaginal candidiasis in mice.
    Wozniak KL, Wormley FL, Fidel PL.
    Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
    [Abstract] [Full Text] [Related]

  • 11. Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis.
    Consuegra-Asprilla JM, Chaverra-Osorio M, Torres B, Cabrera-Chingal Y, Mancera-Mieles A, Rodríguez-Echeverri C, Gómez BL, González Á.
    Med Mycol; 2024 Sep 06; 62(9):. PubMed ID: 39237447
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
    Wozniak KL, Palmer G, Kutner R, Fidel PL.
    Med Mycol; 2005 Nov 06; 43(7):589-601. PubMed ID: 16396244
    [Abstract] [Full Text] [Related]

  • 13. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
    Ge G, Yang Z, Li D, Zhang N, Chen B, Shi D.
    Front Immunol; 2022 Nov 06; 13():959740. PubMed ID: 35967437
    [Abstract] [Full Text] [Related]

  • 14. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.
    Taylor BN, Saavedra M, Fidel PL.
    Med Mycol; 2000 Dec 06; 38(6):419-31. PubMed ID: 11204879
    [Abstract] [Full Text] [Related]

  • 15. Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
    MacAlpine J, Lionakis MS.
    Cell Host Microbe; 2024 Oct 09; 32(10):1654-1667. PubMed ID: 39389030
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of Candida albicans by human vaginal epithelial cells.
    Barousse MM, Steele C, Dunlap K, Espinosa T, Boikov D, Sobel JD, Fidel PL.
    J Infect Dis; 2001 Dec 01; 184(11):1489-93. PubMed ID: 11709796
    [Abstract] [Full Text] [Related]

  • 17. CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.
    Break TJ, Jaeger M, Solis NV, Filler SG, Rodriguez CA, Lim JK, Lee CC, Sobel JD, Netea MG, Lionakis MS.
    Infect Immun; 2015 Mar 01; 83(3):958-65. PubMed ID: 25547797
    [Abstract] [Full Text] [Related]

  • 18. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.
    Fidel PL, Barousse M, Lounev V, Espinosa T, Chesson RR, Dunlap K.
    Med Mycol; 2003 Apr 01; 41(2):97-109. PubMed ID: 12964841
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibition of Candida albicans by vaginal cells from naïve mice.
    Steele C, Ozenci H, Luo W, Scott M, Fidel PL.
    Med Mycol; 1999 Aug 01; 37(4):251-9. PubMed ID: 10421860
    [Abstract] [Full Text] [Related]

  • 20. History and update on host defense against vaginal candidiasis.
    Fidel PL.
    Am J Reprod Immunol; 2007 Jan 01; 57(1):2-12. PubMed ID: 17156186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.